AHR and Parkinson disease: In summary, the modulation of the AHR signalling pathway by tryptamine is pivotal for various physiological processes and may contribute to the development of neurodevelopmental disorders such as ASD and the progression of neurodegenerative diseases such as AD, Huntington's disease, and PD.